CAMX:STO
Camurus AB
739,50 SEK
arrow_downward
-0,07%(-0,50) 1D
20-ноя., 17:29:43 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CAMX...
Open
738,50 SEK
High
745,50 SEK
Low
733,50 SEK
Mkt. cap
44,81 млд
Avg. vol.
103,71 миң
Volume
71,53 миң
52-wk high
750,00 SEK
52-wk low
430,80 SEK
Shares outstanding
60,56 млн
No. of employees
323
Open
738,50 SEK
High
745,50 SEK
Low
733,50 SEK
Mkt. cap
44,81 млд
Avg. vol.
103,71 миң
Volume
71,53 миң
52-wk high
750,00 SEK
52-wk low
430,80 SEK
Shares outstanding
60,56 млн
No. of employees
323
News stories
From web sources and news partners
Forbes
·
28 мүнөт мурун
S&P 500 Falls To 7-Month Low As Tech And AI Concerns Fuel Sell-Off
WSJ
·
12 саат мурун
S&P 500 Flirts With Correction
The Motley Fool
·
34 мүнөт мурун
If I Could Tell All S&P 500 Investors Just 1 Thing Right Now, It's This
Barron's
·
9 саат мурун
S&P 500 Futures Decline in Premarket Trading; Lennar, Louisiana-Pacific Lag
Profile
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
About Camurus AB
CEOFredrik Tiberg
Employees323
Founded1991
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitecamurus.com